EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The role of Spanish clinical pharmacologists in economic evaluations of health technologies

Claudia Erika Delgado-Espinoza, Rosa M Antonijoan, María Jose Martínez-Zapata

European Journal of Clinical Pharmacology · 2026-06 · 82 (6)

DOI: 10.1007/s00228-026-04070-2 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Clinical Pharmacology, online erschienen am 07.05.2026. Verfasst von Claudia Erika Delgado-Espinoza und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology and Therapeutics, Universitat Autónoma de Barcelona (UAB), Barcelona, Spain. ClaudiaErika.Delgado@uab.cat. Hauptthemen laut MEDLINE: Pharmacology, Clinical, Biomedical Technology, Professional Role. Die Arbeit nennt 16 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Universitat Autònoma de Barcelona.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

This study aimed to describe the role and perceptions of clinical pharmacologists (CPs) in conducting economic evaluations of health technologies within the Spanish National Health System from a healthcare provider perspective.

Methods

We conducted a cross-sectional descriptive study using an online survey distributed to members of the Spanish Society of Clinical Pharmacology between September 2024 and September 2025. Eligible participants were CPs working within or linked to the Spanish National Health System. The questionnaire included four sections addressing respondent characteristics, direct involvement in economic evaluations, economic evaluations conducted by other professionals, and training and opinions. Data were analyzed using descriptive statistics.

Results

Of 106 eligible CPs working within or linked to the Spanish National Health System, 48 completed the survey (response rate: 45.3%). The mean age was 51 years, and 56.3% were women. More than half of respondents (54.2%) reported conducting or having conducted economic evaluations, mainly cost-effectiveness and cost-minimisation analyses, often in collaboration with other healthcare professionals. Results were integrated into care protocols in 15 cases, although follow-up and outcome verification were performed in 7 cases. Among CPs not directly involved, 63.7% reported that economic evaluations are conducted at their centres by other professionals. Despite 91.7% of respondents considered that economic evaluation of health technologies is an activity that should be conducted in their centres, and all considered that a CP should participate in these evaluations, only 35.4% felt sufficiently trained, while 77.1% expressed interest in further training.

Conclusion

Among the surveyed CPs, there is active involvement and a high level of motivation to participate in economic evaluations of health technologies in Spain. Strengthening training opportunities and collaborative networks could enhance their contribution to value-based healthcare.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pharmacology, ClinicalBiomedical TechnologyProfessional RoleHumansFemaleSpainMiddle AgedMaleCross-Sectional StudiesCost-Benefit AnalysisAdultSurveys and QuestionnairesCost-Effectiveness Analysis

Stichwörter der Autor:innen

Clinical pharmacologistsEconomic evaluationsHealth technologiesHealthcare provider’s perspectiveSpanish national health system

Autor:innen und Institutionen

  • Department of Pharmacology and Therapeutics, Universitat Autónoma de Barcelona (UAB), Barcelona, Spain. ClaudiaErika.Delgado@uab.cat.
  • Department of Clinical Pharmacology, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain. ClaudiaErika.Delgado@uab.cat.
  • Institut de Recerca Sant Pau (IR SANTPAU), Barcelona, Spain. ClaudiaErika.Delgado@uab.cat.
  • Department of Pharmacology and Therapeutics, Universitat Autónoma de Barcelona (UAB), Barcelona, Spain.
  • Department of Clinical Pharmacology, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.
  • Institut de Recerca Sant Pau (IR SANTPAU), Barcelona, Spain.

Förderung

  • Universitat Autònoma de Barcelona

Zitieren

APA

Delgado-Espinoza, C. E., Antonijoan, R. M., & Martínez-Zapata, M. J. (2026). The role of Spanish clinical pharmacologists in economic evaluations of health technologies. European Journal of Clinical Pharmacology, 82(6). https://doi.org/10.1007/s00228-026-04070-2

Vancouver

Delgado-Espinoza CE, Antonijoan RM, Martínez-Zapata MJ. The role of Spanish clinical pharmacologists in economic evaluations of health technologies. European Journal of Clinical Pharmacology. 2026;82(6). doi:10.1007/s00228-026-04070-2

BibTeX
@article{DelgadoEspinoza2026,
  author = {Delgado-Espinoza, Claudia Erika and Antonijoan, Rosa M and Martínez-Zapata, María Jose},
  title = {The role of Spanish clinical pharmacologists in economic evaluations of health technologies},
  journal = {European Journal of Clinical Pharmacology},
  year = {2026},
  volume = {82},
  number = {6},
  doi = {10.1007/s00228-026-04070-2}
}
Kostenlos starten →